Back to Results

Malin Corporation plc (MLLNF)

Malin Corporation plc is a Dublin-based investment company with operations in Europe and North America. Through its subsidiaries, it focuses on investing in life sciences and healthcare businesses across areas such as oncology, immunology, and genetic diseases. Founded in 2014, the company is listed on OTC Markets as common stock under the symbol MLLN.F.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-MLLN.F
$5.53
-13.6% Downside
Fair
—
—
—
Good
—
—
—
0.0%
August 27, 2026
-4.5x
0.8x
—
35.156 M
21.005 M
0.0%
20.6%
21.4
—
13.0%
Valuation • Fair Value

Malin Corporation plc (OTC-MLLN.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Malin Corporation plc (OTC-MLLN.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$5.53

Estimated downside of 13.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$5.53

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Malin Corporation plc (OTC-MLLN.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Malin Corporation plc (OTC-MLLN.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

-3.427 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Malin Corporation plc (OTC-MLLN.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Malin Corporation plc (OTC-MLLN.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

21.4

Relatively strong balance-sheet zone.

FCF / Net Income

13.0%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Malin Corporation plc (OTC-MLLN.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Malin Corporation plc (OTC-MLLN.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 27, 2026

Days to Earnings

37

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Malin Corporation plc (OTC-MLLN.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Malin Corporation plc (OTC-MLLN.F) Stock Forecast & Technical Outlook

Review Malin Corporation plc (OTC-MLLN.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Malin Corporation plc (OTC-MLLN.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Malin Corporation plc (OTC-MLLN.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Malin Corporation plc (OTC-MLLN.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Malin Corporation plc (OTC-MLLN.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Buy

The monthly technical read for Malin Corporation plc (OTC-MLLN.F) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Malin Corporation plc (OTC-MLLN.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Malin Corporation plc (OTC-MLLN.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Malin Corporation plc (OTC-MLLN.F) Stock FAQ

Quick answers about Malin Corporation plc (OTC-MLLN.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$5.53
Estimated downside 13.6%
Valuation Rating
Overvalued
Estimated downside of 13.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for Malin Corporation plc (OTC-MLLN.F) is $5.53. This implies an estimated downside of 13.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 13.6% versus the current market price.

An analyst price target for Malin Corporation plc (OTC-MLLN.F) is not currently available in the latest data file.

The current financial health read for Malin Corporation plc (OTC-MLLN.F) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Malin Corporation plc (OTC-MLLN.F) is August 27, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Malin Corporation plc (OTC-MLLN.F) is -4.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Malin Corporation plc is 35.156 M.

The current enterprise value listed for Malin Corporation plc is 21.005 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Malin Corporation plc is OTC-MLLN.F, and the stock is listed on OTC Markets.

Malin Corporation plc (OTC-MLLN.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Malin Corporation plc is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Malin Corporation plc is 20.6%. Free float helps investors understand how much of the share base is available for public trading.

Similar Life Sciences Tools & Services Stocks on OTC Markets View more

Lonza Group AG (LZAGY) Lonza Group AG (LZAGY)
WuXi Biologics (WXIBF) WuXi Biologics (WXIBF)
RADNOSTIX, INC (INIS) RADNOSTIX, INC (INIS)
Bioqual Inc (BIOQ) Bioqual Inc (BIOQ)
Sona Nanotech Inc (SNANF) Sona Nanotech Inc (SNANF)
Pharma-Bio Serv Inc (PBSV) Pharma-Bio Serv Inc (PBSV)
Reflect Scientific Inc (RSCF) Reflect Scientific Inc (RSCF)
Cannabis Bioscience International Holdings Inc (CBIH) Cannabis Bioscience International Holdings Inc (CBIH)
BNB Plus Corp (BNBX) BNB Plus Corp (BNBX)
Pressure Biosciences Inc (PBIO) Pressure Biosciences Inc (PBIO)
EVIO Inc (EVIO) EVIO Inc (EVIO)
MetaStat Inc (MTST) MetaStat Inc (MTST)
Telesis Bio Inc (TBIO) Telesis Bio Inc (TBIO)
BG Medicine Inc (BGMD) BG Medicine Inc (BGMD)
Arrayit Corporation (ARYC) Arrayit Corporation (ARYC)
Response Genetics Inc (RGDXQ) Response Genetics Inc (RGDXQ)